ADVERTISEMENT
Posted: Apr 7, 2024

Get ready: COVID-19 therapeutics transition to the commercial market

COVID-19 Antivirals

As pandemic uncertainty dissipates, COVID-19 therapeutics are transitioning from U.S. government- procured sources to the commercial market.

Clarissa Chan, PharmD

Read more
Posted: Apr 7, 2024

Barriers still present for OUD medications even after passage of MAT Act

Opioid Use Disorder

Even after passage of the Mainstreaming Addiction Treatment (MAT) Act in late 2023, patients still face difficulty gaining access to buprenorphine—the gold standard for treating patients with OUD.

Parth Patel, PharmD

Read more
Posted: Apr 7, 2024

Use of gabapentin in U.S. shows no sign of slowing

Gabapentin

Gabapenti.noid use has continued to climb in the United States, despite a lack of strong evidence for its effectiveness in pain management and other uses, according to a recent study published in the January 2024 issue of the Annals of Family Medicine.

Elizabeth Briand

Read more
Posted: Apr 7, 2024

Prebiotics: A gut check

On The Shelf

Prebiotic dietary supplements boast that they promote digestive health, reduce inflammation, increase energy and drive, and may help with appetite control. All this and they're also vegan, gluten-free, sugar-free, and keto-friendly. What are prebiotics, anyway?

Mickie Cathers

Read more
Posted: Apr 7, 2024

Muscle aches and pain

OTCs Today

Everyone experiences muscle pain (myalgia) at some point in their lives, whether due to overexertion, injury, or disease. Fortunately, numerous options, including 1·est, massage, and medications, are available to relieve the pain.

Mary Warner

 

Read more
12

Related Articles

Advertisement
Advertisement
Advertisement
Advertisement
ADVERTISEMENT